Ruta Graveolens 10x
Generic Name: ruta graveolens 10x
Dosage form: LIQUID. Active ingredients: RUTA GRAVEOLENS FLOWERING TOP (10 [hp_X]/L). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: RUTA GRAVEOLENS FLOWERING TOP (10 [hp_X]/L). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Factor Ix Complex
factor ix complex
Dosage form: KIT. Route: INTRAVENOUS. Category: BLA.
Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Lycopodium Clavatum, Phosphorus, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum, Cesium Chloride, Chromium, Cobaltum Metallicum, Cuprum Metallicum, Dysprosium Metallicum, Erbium Metallicum, Europium Metallicum, Ferrum Metallicum, Gadolinium Metallicum, Germanium Sesquioxide,
agaricus muscarius, coccus cacti, conium maculatum, lycopodium clavatum, phosphorus, aluminium metallicum, antimonium crudum, argentum metallicum, arsenicum album, aurum metallicum, baryta carbonica, beryllium metallicum, bismuthum metallicum, boron, bromium, cadmium metallicum, cerium metallicum, cesium chloride, chromium, cobaltum metallicum, cuprum metallicum, dysprosium metallicum, erbium metallicum, europium metallicum, ferrum metallicum, gadolinium metallicum, germanium sesquioxide,
Acetylcholine Release Inhibitor [EPC]
PURPOSE: For temporary relief of symptoms due to numbness, tingling, muscle cramps, and nerve pain.
Paltusotine
paltusotine
11 DESCRIPTION PALSONIFY tablets contain paltusotine hydrochloride, a somatostatin receptor agonist. Paltusotine is known chemically as 3-[4-(4-Amino-1-piperidinyl)-3-(3,5-difluorophenyl)-6-quinolinyl]-2-hydroxybenzonitrile hydrochloride. The molecular weight of paltusotine hydrochloride is 492.95 g/mol (C 27 H 22 F 2 N 4 O·HCl).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.